These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 1891022)
1. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. Clarke RJ; Mayo G; Price P; FitzGerald GA N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384 [TBL] [Abstract][Full Text] [Related]
3. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523 [TBL] [Abstract][Full Text] [Related]
4. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2. FitzGerald GA; Lupinetti M; Charman SA; Charman WN J Pharmacol Exp Ther; 1991 Dec; 259(3):1043-9. PubMed ID: 1762060 [TBL] [Abstract][Full Text] [Related]
5. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. Christman BW; McPherson CD; Newman JH; King GA; Bernard GR; Groves BM; Loyd JE N Engl J Med; 1992 Jul; 327(2):70-5. PubMed ID: 1603138 [TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin. Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252 [TBL] [Abstract][Full Text] [Related]
7. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase. Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223 [TBL] [Abstract][Full Text] [Related]
8. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865 [TBL] [Abstract][Full Text] [Related]
9. In the dose range of 0.5-2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies. Vainio M; Mäenpää J; Riutta A; Ylitalo P; Ala-Fossi SL; Tuimala R Acta Obstet Gynecol Scand; 1999 Feb; 78(2):82-8. PubMed ID: 10023867 [TBL] [Abstract][Full Text] [Related]
10. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. Pedersen AK; FitzGerald GA N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696 [TBL] [Abstract][Full Text] [Related]
11. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. Weksler BB; Pett SB; Alonso D; Richter RC; Stelzer P; Subramanian V; Tack-Goldman K; Gay WA N Engl J Med; 1983 Apr; 308(14):800-5. PubMed ID: 6339916 [TBL] [Abstract][Full Text] [Related]
12. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects. Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329 [TBL] [Abstract][Full Text] [Related]
13. Selective and nonselective inhibition of thromboxane formation. FitzGerald GA; Oates JA Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554 [TBL] [Abstract][Full Text] [Related]
14. Absence of differential inhibition of thromboxane A2 and prostacyclin by low and high dose aspirin in coronary artery disease. Klein RC; Beckman J; Peake G Can J Cardiol; 1987 Sep; 3(6):288-92. PubMed ID: 3322532 [TBL] [Abstract][Full Text] [Related]
15. Improvement of renal function with selective thromboxane antagonism in lupus nephritis. Pierucci A; Simonetti BM; Pecci G; Mavrikakis G; Feriozzi S; Cinotti GA; Patrignani P; Ciabattoni G; Patrono C N Engl J Med; 1989 Feb; 320(7):421-5. PubMed ID: 2643773 [TBL] [Abstract][Full Text] [Related]
16. An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause. Jendryczko A; Tomala J Zentralbl Gynakol; 1993; 115(4):163-6. PubMed ID: 8503234 [TBL] [Abstract][Full Text] [Related]
17. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis. Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418 [TBL] [Abstract][Full Text] [Related]
18. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. Knapp HR; Reilly IA; Alessandrini P; FitzGerald GA N Engl J Med; 1986 Apr; 314(15):937-42. PubMed ID: 3007982 [TBL] [Abstract][Full Text] [Related]
19. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043 [TBL] [Abstract][Full Text] [Related]